SYRE
USDSpyre Therapeutics Inc. Common Stock
Prix en Temps Réel
Graphique des Prix
Métriques Clés
Métriques de Marché
Ouverture
$21.880
Haut
$22.540
Bas
$21.150
Volume
0.80M
Fondamentaux de l'Entreprise
Capitalisation Boursière
1.7B
Industrie
Biotechnologie
Pays
United States
Statistiques de Trading
Volume Moyen
0.83M
Bourse
NMS
Devise
USD
Intervalle sur 52 Semaines
Actualités Connexes
Spyre Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Reported positive interim Phase 1 results for SPY003, a next-generation anti-IL-23 antibody, demonstrating the molecule was well-tolerated and exhibited an ~85-day half-life supporting quarterly or twice annual
Spyre Therapeutics to Participate in Upcoming November Investor Conferences
WALTHAM, Mass., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ:SYRE), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of
Spyre Therapeutics Announces Poster Presentations at American College of Rheumatology (ACR) Convergence 2025
WALTHAM, Mass., Oct. 24, 2025 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ:SYRE), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of
Actions Connexes
FCUV
Focus Universal Inc.
FTAIO
FTAI Aviation Ltd. 8.00% Fixed-to-Floating Rate Series B Cumulative Perpetual Redeemable Preferred Shares
PPG
PPG Industries Inc.
FINW
FinWise Bancorp
UIS
Unisys Corporation New
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.